CJC-1295 (No DAC) + Ipamorelin 5mg/5mg
A co-lyophilized blend of CJC-1295 (no DAC) and Ipamorelin, 5mg of each per vial — the standard GHRH + GHRP pairing used to study synergistic growth-hormone release. ≥99% HPLC purity.
Volume pricing — buy more, pay less per vial
Select a tier to set the quantity. Discount is applied automatically at checkout.
COA with every batch
Independent EU lab, ≥99% HPLC
Secure encrypted checkout
Card payments over TLS
Discreet packaging
Plain outer box, no branding
EU dispatch in 24–48h
Tracked delivery
Cold-chain handling
Temperature-controlled transit
About this compound
What Is This Blend?
This vial contains 5mg CJC-1295 without DAC and 5mg Ipamorelin, co-lyophilized together. It pairs a GHRH analogue with a selective growth-hormone secretagogue — the two act on different receptors on the same pituitary cell, which is why the combination is one of the most-studied synergistic pairings in growth-hormone research.
Why the Two Are Combined
- CJC-1295 (GHRH receptor) — increases the amplitude of each growth-hormone pulse and drives synthesis of new GH within the somatotroph
- Ipamorelin (ghrelin receptor / GHS-R1a) — triggers release of stored GH and simultaneously suppresses somatostatin, the brake on GH secretion
- Net effect — removing the brake while pressing the accelerator produces GH output greater than either compound achieves alone
- Selectivity — unlike GHRP-6 or GHRP-2, Ipamorelin does not meaningfully raise cortisol, prolactin or ACTH
Research Applications
- Synergistic GH secretagogue pharmacology
- GH/IGF-1 axis and pulsatility research
- Body composition, recovery and sleep-quality models
- Comparative studies against single-agent GHRH or GHRP protocols
Handling
Supplied co-lyophilized in a single vial. Reconstitute with bacteriostatic water. Store the sealed vial at 2–8 °C; refrigerate after reconstitution and use within 28 days.
Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary use, not for consumption.
Specifications
- Composition
- CJC-1295 no DAC 5mg + Ipamorelin 5mg (co-lyophilized)
- Molecular Weight
- CJC-1295: 3367.9 Da · Ipamorelin: 711.9 Da
- Half-Life
- CJC-1295: ~30 min · Ipamorelin: ~2 h
- Vial Size
- 5mg / 5mg
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized powder
- Reconstitution
- Bacteriostatic water (0.9% benzyl alcohol)
- Storage
- Sealed: 2–8 °C · Reconstituted: 2–8 °C, use within 28 days
Research library
Full mechanism breakdowns and peer-reviewed references for each compound in this blend.
📈 CJC-1295
GHRH Analogue
Long-acting GHRH analogue. Stimulates pituitary GH release in pulses. Combined with Ipamorelin for synergistic GH secretion. DAC (Drug Affinity Complex) extends half-life from 30 min to 6–8 days.
📈 Ipamorelin
Selective GHRP
Selective GH secretagogue. Stimulates GH release without elevating cortisol or prolactin — cleaner GH stimulus than older GHRPs. Stack with CJC-1295 for synergistic GH amplification.
Frequently asked questions
Related research compounds
For laboratory and in-vitro research use only. Not for human or veterinary use, not for consumption. By purchasing, you confirm you are a qualified researcher and accept full responsibility for compliant handling and disposal. Read the full disclaimers.